202 related articles for article (PubMed ID: 2156516)
1. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance.
Rao KE; Shea RG; Yadagiri B; Lown JW
Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies.
Lee M; Krowicki K; Shea RG; Lown JW; Pon RT
J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition between oligopeptides and nucleic acids: DNA binding selectivity of a series of 1,2,4-triazole-containing lexitropsins.
Rao KE; Krowicki K; Burckhardt G; Zimmer C; Lown JW
Chem Res Toxicol; 1991; 4(2):241-52. PubMed ID: 1664260
[TBL] [Abstract][Full Text] [Related]
5. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
Bailly C; Hénichart JP; Colson P; Houssier C
J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
[TBL] [Abstract][Full Text] [Related]
6. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
7. [Specific protection of DNA by distamycin A, netropsin and bis-netropsins against the action of DNAse I].
Skamrov AV; Rybalkin IN; Bibilashvili RSh; Gottikh BP; Grokhovskiĭ SL
Mol Biol (Mosk); 1985; 19(1):177-95. PubMed ID: 2984546
[TBL] [Abstract][Full Text] [Related]
8. Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes.
Lown JW
Anticancer Drug Des; 1988 Jun; 3(1):25-40. PubMed ID: 2838035
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition between oligopeptides and nucleic acids: novel imidazole-containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity.
Lown JW; Krowicki K; Bhat UG; Skorobogaty A; Ward B; Dabrowiak JC
Biochemistry; 1986 Nov; 25(23):7408-16. PubMed ID: 3026455
[TBL] [Abstract][Full Text] [Related]
10. Short lexitropsin that recognizes the DNA minor groove at 5'-ACTAGT-3': understanding the role of isopropyl-thiazole.
Anthony NG; Johnston BF; Khalaf AI; MacKay SP; Parkinson JA; Suckling CJ; Waigh RD
J Am Chem Soc; 2004 Sep; 126(36):11338-49. PubMed ID: 15355117
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition and binding of a GC site-avoiding thiazole-lexitropsin to the decadeoxyribonucleotide d-[CGCAATTGCG]2: 1H-NMR evidence for thiazole intercalation.
Kumar S; Jaseja M; Zimmermann J; Yadagiri B; Pon RT; Sapse AM; Lown JW
J Biomol Struct Dyn; 1990 Aug; 8(1):99-121. PubMed ID: 2177339
[TBL] [Abstract][Full Text] [Related]
12. FTIR study of specific binding interactions between DNA minor groove binding ligands and polynucleotides.
Adnet F; Liquier J; Taillandier E; Singh MP; Rao KE; Lown JW
J Biomol Struct Dyn; 1992 Dec; 10(3):565-75. PubMed ID: 1283517
[TBL] [Abstract][Full Text] [Related]
13. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.
Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV
J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560
[TBL] [Abstract][Full Text] [Related]
14. Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand.
Bailly C; Helbecque N; Hénichart JP; Colson P; Houssier C; Rao KE; Shea RG; Lown JW
J Mol Recognit; 1990 Feb; 3(1):26-35. PubMed ID: 2354061
[TBL] [Abstract][Full Text] [Related]
15. Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA.
Plouvier B; Houssin R; Helbecque N; Colson P; Houssier C; Hénichart JP; Bailly C
Anticancer Drug Des; 1995 Mar; 10(2):155-66. PubMed ID: 7710636
[TBL] [Abstract][Full Text] [Related]
16. Psoralen--lexitropsin hybrids: DNA sequence selectivity of photoinduced cross-linking from MPE footprinting and exonuclease III stop assay, and mode of binding from electric linear dichroism.
Rao KE; Gosselin G; Mrani D; Périgaud C; Imbach JL; Bailly C; Hénichart JP; Colson P; Houssier C; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):221-37. PubMed ID: 8031454
[TBL] [Abstract][Full Text] [Related]
17. The binding of prototype lexitropsins to the minor groove of DNA: quantum chemical studies.
Mazurek P; Feng W; Shukla K; Sapse AM; Lown JW
J Biomol Struct Dyn; 1991 Oct; 9(2):299-313. PubMed ID: 1660279
[TBL] [Abstract][Full Text] [Related]
18. Variation of DNA sequence specificity of DNA-oligopeptide binding ligands related to netropsin: imidazole-containing lexitropsins.
Burckhardt G; Luck G; Zimmer C; Störl J; Krowicki K; Lown JW
Biochim Biophys Acta; 1989 Sep; 1009(1):11-8. PubMed ID: 2551381
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA binding, sequence preference and biological evaluation of minor groove-selective N1-alkoxyalkyl-bis-benzimidazoles.
Wang H; Gupta R; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):153-60. PubMed ID: 8031450
[TBL] [Abstract][Full Text] [Related]
20. Control over the sequence specificity of DNA alkylation: syntheses and reactions with 32P-end-labelled DNA of N-alkyl-N-nitrosoureas linked to minor groove binding lexitropsins.
Gold B; Church KM; Wurdeman RL; Zhang Y; Chen FX
IARC Sci Publ; 1991; (105):439-42. PubMed ID: 1649793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
